Krystal Biotech
KRYS
$159.67
Share price
4.28%
Change (1 day)
85.25%
Change (1 year)
Krystal Biotech (KRYS) - Cash on Hand
Cash on Hand as of December 2023 : $0.53 B
According to Krystal Biotech's latest financial reports the company has $0.53 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Krystal Biotech - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.53 B | 40.35% |
| 2022-12-31 | $0.37 B | -13.45% |
| 2021-12-31 | $0.43 B | 61.5% |
| 2020-12-31 | $0.27 B | 40.05% |
| 2019-12-31 | $0.19 B | 73.3% |
| 2018-12-31 | $0.11 B | 125.37% |
| 2017-12-31 | $49.59 M | 2478.84% |
| 2016-12-31 | $1.92 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -60.88% | 🇺🇸 USA |